Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

Hydroxocobalamin

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1392-2015
Class II · Moderate risk

Doxycycline/0.9 % NaCl 100 mg/100 mL IV

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1390-2015
Class II · Moderate risk

Tobramycin 14 mg/mL Ophthalmic Solution

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1389-2015
Class II · Moderate risk

Doxcycline/0.9% NaCl 150 mg/150 mL IV

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1388-2015
Class II · Moderate risk

Vancomycin 25 mg/mL Opthalmic Solution

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1387-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1386-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1385-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1384-2015
Class II · Moderate risk

Methylcobalamin 5000 mcg/mL Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1382-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1381-2015
Class II · Moderate risk

Cyanocobalamin 500 mcg/mL Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1380-2015
Class I · High risk

PYROLA Advanced Joint Formula capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and chlorpheniramine, an over-the-counter antihistimine, making this an unapproved drug.

Terminated Chemical / undeclared GC Natural Nutrition, Inc. D-1330-2015
Class II · Moderate risk

OXYCODONE HCl C-II Tablets

Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.

Terminated Wrong potency / content The Harvard Drug Group, LLC NDC 0904-6444-61 D-1150-2015
Class II · Moderate risk

NEXIUM¿ (esomeprazole magnesium)

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Terminated Particulate / foreign matter AstraZeneca Pharmaceuticals LP NDC 00186-5020-31 D-1141-2015
Class II · Moderate risk

Trypan Blue 0.3%

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1056-2016
Class II · Moderate risk

Brilliant Blue G BBG

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1055-2016
Class II · Moderate risk

Methylcobalamin 5

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1054-2016
Class II · Moderate risk

METHYLFOLATE Capsules

Penicillin Cross Contamination: potentially contaminated with penicillin

Terminated Cross-contamination Life Science Pharmacy Inc D-0505-2016
Class II · Moderate risk

TRI-EST Gels

Penicillin Cross Contamination: potentially contaminated with penicillin

Terminated Cross-contamination Life Science Pharmacy Inc D-0504-2016
Class II · Moderate risk

TRI-EST Liquids

Penicillin Cross Contamination: potentially contaminated with penicillin

Terminated Cross-contamination Life Science Pharmacy Inc D-0503-2016

Recalls by year